rs398124655

Positions:

• chr8-119793396-G-T

Variant summary

Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2 PP2 PP3_Moderate

The NM_003184.4(TAF2):​c.1247C>A​(p.Pro416His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,680 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

• Frequency:
  • Genomes: not found (cov: 32)
  • Exomes 𝑓: 6.8e-7 (0 hom.)
• Consequence: TAF2 NM_003184.4 missense
• Clinical Significance: Uncertain significance criteria provided, single submitter U:2
• Conservation: PhyloP100: 9.44

Genes affected

TAF2 (HGNC:11536): (TATA-box binding protein associated factor 2) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the larger subunits of TFIID that is stably associated with the TFIID complex. It contributes to interactions at and downstream of the transcription initiation site, interactions that help determine transcription complex response to activators. [provided by RefSeq, Jul 2008]

TAF2 (HGNC:):

ACMG classification

Verdict is Uncertain_significance. Variant got 5 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• PP2: Missense variant in gene, where missense usually causes diseases (based on misZ statistic), TAF2. . Gene score misZ 2.7836 (greater than the threshold 3.09). Trascript score misZ 3.5113 (greater than threshold 3.09). GenCC has associacion of gene with microcephaly-thin corpus callosum-intellectual disability syndrome.
• PP3: MetaRNN computational evidence supports a deleterious effect, 0.901

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
TAF2	NM_003184.4	c.1247C>A	p.Pro416His	missense_variant	10/26	ENST00000378164.7	NP_003175.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
TAF2	ENST00000378164.7	c.1247C>A	p.Pro416His	missense_variant	10/26	1	NM_003184.4	ENSP00000367406.2
TAF2	ENST00000686879.1	c.1247C>A	p.Pro416His	missense_variant	10/27			ENSP00000509206.1
TAF2	ENST00000685235.1	c.1247C>A	p.Pro416His	missense_variant	10/26			ENSP00000510174.1
TAF2	ENST00000688645.1	c.1247C>A	p.Pro416His	missense_variant	10/25			ENSP00000509978.1
TAF2	ENST00000523904.2	c.1133C>A	p.Pro378His	missense_variant	9/25	3		ENSP00000430832.2
TAF2	ENST00000690144.1	c.1247C>A	p.Pro416His	missense_variant	10/26			ENSP00000510548.1
TAF2	ENST00000685202.1	n.1247C>A		non_coding_transcript_exon_variant	10/27			ENSP00000509214.1
TAF2	ENST00000685663.1	n.*1119C>A		non_coding_transcript_exon_variant	12/28			ENSP00000508988.1
TAF2	ENST00000685684.1	n.*2714C>A		non_coding_transcript_exon_variant	9/25			ENSP00000509441.1
TAF2	ENST00000685824.1	n.*948C>A		non_coding_transcript_exon_variant	8/24			ENSP00000510262.1
TAF2	ENST00000685876.1	n.*965C>A		non_coding_transcript_exon_variant	11/27			ENSP00000510493.1
TAF2	ENST00000685993.1	n.*1062C>A		non_coding_transcript_exon_variant	9/25			ENSP00000510102.1
TAF2	ENST00000688037.1	n.*666C>A		non_coding_transcript_exon_variant	7/23			ENSP00000510169.1
TAF2	ENST00000689919.1	n.*965C>A		non_coding_transcript_exon_variant	11/26			ENSP00000510768.1
TAF2	ENST00000690808.1	n.*483C>A		non_coding_transcript_exon_variant	10/26			ENSP00000509791.1
TAF2	ENST00000690922.1	n.1247C>A		non_coding_transcript_exon_variant	10/26			ENSP00000509498.1
TAF2	ENST00000691880.1	n.*903C>A		non_coding_transcript_exon_variant	9/25			ENSP00000508515.1
TAF2	ENST00000692518.1	n.*948C>A		non_coding_transcript_exon_variant	8/25			ENSP00000508959.1
TAF2	ENST00000692707.1	n.*1115C>A		non_coding_transcript_exon_variant	12/28			ENSP00000509024.1
TAF2	ENST00000692916.1	n.*634C>A		non_coding_transcript_exon_variant	9/25			ENSP00000509603.1
TAF2	ENST00000685663.1	n.*1119C>A		3_prime_UTR_variant	12/28			ENSP00000508988.1
TAF2	ENST00000685684.1	n.*2714C>A		3_prime_UTR_variant	9/25			ENSP00000509441.1
TAF2	ENST00000685824.1	n.*948C>A		3_prime_UTR_variant	8/24			ENSP00000510262.1
TAF2	ENST00000685876.1	n.*965C>A		3_prime_UTR_variant	11/27			ENSP00000510493.1
TAF2	ENST00000685993.1	n.*1062C>A		3_prime_UTR_variant	9/25			ENSP00000510102.1
TAF2	ENST00000688037.1	n.*666C>A		3_prime_UTR_variant	7/23			ENSP00000510169.1
TAF2	ENST00000689919.1	n.*965C>A		3_prime_UTR_variant	11/26			ENSP00000510768.1
TAF2	ENST00000690808.1	n.*483C>A		3_prime_UTR_variant	10/26			ENSP00000509791.1
TAF2	ENST00000691880.1	n.*903C>A		3_prime_UTR_variant	9/25			ENSP00000508515.1
TAF2	ENST00000692518.1	n.*948C>A		3_prime_UTR_variant	8/25			ENSP00000508959.1
TAF2	ENST00000692707.1	n.*1115C>A		3_prime_UTR_variant	12/28			ENSP00000509024.1
TAF2	ENST00000692916.1	n.*634C>A		3_prime_UTR_variant	9/25			ENSP00000509603.1
TAF2	ENST00000685503.1	n.*670-1937C>A		intron_variant				ENSP00000509198.1
TAF2	ENST00000686098.1	n.1192-1937C>A		intron_variant				ENSP00000509102.1
TAF2	ENST00000689164.1	n.1078-1937C>A		intron_variant				ENSP00000508729.1
TAF2	ENST00000691847.1	n.*579-1937C>A		intron_variant				ENSP00000509663.1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome AF: 6.85e-7 AC: 1 AN: 1460680 Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1 AN XY: 726722

Gnomad4 AFR exome AF: 0.0000299

Gnomad4 AMR exome AF: 0.00

Gnomad4 ASJ exome AF: 0.00

Gnomad4 EAS exome AF: 0.00

Gnomad4 SAS exome AF: 0.00

Gnomad4 FIN exome AF: 0.00

Gnomad4 NFE exome AF: 0.00

Gnomad4 OTH exome AF: 0.00

GnomAD4 genome Cov.: 32

ClinVar

Significance: Uncertain significance

Submissions summary: Uncertain:2

Revision: criteria provided, single submitter

Submissions by phenotype

not provided Uncertain:1

Uncertain significance, criteria provided, single submitter

clinical testing

CeGaT Center for Human Genetics Tuebingen

Mar 01, 2019

- -

Microcephaly-thin corpus callosum-intellectual disability syndrome Uncertain:1

Uncertain significance, no assertion criteria provided

literature only

OMIM

Dec 01, 2013

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Pathogenic	0.85
BayesDel_addAF	Uncertain	0.12	D
BayesDel_noAF	Uncertain	-0.070
CADD	Uncertain	25
DANN	Uncertain	1.0
DEOGEN2	Benign	0.24	T
Eigen	Uncertain	0.60
Eigen_PC	Pathogenic	0.68
FATHMM_MKL	Pathogenic	0.99	D
LIST_S2	Uncertain	0.94	D
M_CAP	Benign	0.070	D
MetaRNN	Pathogenic	0.90	D
MetaSVM	Benign	-0.80	T
MutationAssessor	Benign	1.4	L
PrimateAI	Pathogenic	0.82	D
PROVEAN	Pathogenic	-6.8	D
REVEL	Uncertain	0.41
Sift	Uncertain	0.0010	D
Sift4G	Pathogenic	0.0	D
Polyphen		0.74	P
Vest4		0.90
MutPred		0.76		Loss of loop (P = 0.0112);
MVP		0.38
MPC		0.79
ClinPred		0.99	D
GERP RS		5.7
Varity_R		0.78
gMVP		0.90

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.020		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs398124655; hg19: chr8-120805636;